In addition, a recent study conducted by Nazmi and co-workers reported increased survival in mice treated with a TLR7 agonist compared with wild-type mice due to the use of lethal dose of JEV (GP78 strain, 3 × 105 pfu/mouse) through subcutaneous route to induce infection. The gene discussed is TLR7; the disease is infection.